NewLink Genetics Corp (NASDAQ:NLNK)

43.08
Delayed Data
As of Feb 27
 +0.95 / +2.25%
Today’s Change
17.32
Today|||52-Week Range
50.46
+8.38%
Year-to-Date

Today’s Trading

Previous close42.13
Today’s open42.51
Day’s range41.53 - 43.18
Volume543,831
Average volume (3 months)445,060
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-32.11%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book19.63

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...-2.74-6.49%
USNAUSANA Health Science...-4.97-4.73%
PDLIPDL BioPharma Inc+0.03+0.43%
MACKMerrimack Pharmaceut...-0.05-0.46%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account